Dialogue Health Technologies (OTCMKTS:DLHTF) PT Lowered to C$5.00 at Desjardins

Dialogue Health Technologies (OTCMKTS:DLHTFGet Rating) had its price target lowered by stock analysts at Desjardins from C$7.50 to C$5.00 in a research report issued to clients and investors on Wednesday, The Fly reports.

DLHTF has been the topic of several other reports. TD Securities reduced their price target on Dialogue Health Technologies from C$4.50 to C$3.50 in a research note on Wednesday, September 21st. Canaccord Genuity Group reduced their price target on Dialogue Health Technologies from C$6.00 to C$5.00 in a research note on Wednesday. Royal Bank of Canada dropped their target price on Dialogue Health Technologies from C$6.00 to C$5.00 in a report on Friday, September 23rd. Scotiabank dropped their target price on Dialogue Health Technologies from C$8.00 to C$5.50 in a report on Wednesday. Finally, National Bank Financial dropped their target price on Dialogue Health Technologies from C$8.50 to C$6.75 in a report on Wednesday.

Dialogue Health Technologies Stock Performance

DLHTF opened at 2.07 on Wednesday. Dialogue Health Technologies has a 52-week low of 2.07 and a 52-week high of 4.75. The company’s 50 day simple moving average is 2.09.

Dialogue Health Technologies Company Profile

(Get Rating)

Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.

See Also

The Fly logo

Receive News & Ratings for Dialogue Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dialogue Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.